key: cord-0791313-xb02s3kz
authors: Kikuchi, Kan; Nangaku, Masaomi; Ryuzaki, Munekazu; Yamakawa, Tomoyuki; Hanafusa, Norio; Sakai, Ken; Kanno, Yoshihiko; Ando, Ryoichi; Shinoda, Toshio; Nakamoto, Hidetomo; Akizawa, Tadao
title: COVID‐19 in dialysis patients in Japan: Current status and guidance on preventive measures
date: 2020-06-07
journal: Ther Apher Dial
DOI: 10.1111/1744-9987.13531
sha: 54f80c289e30094345716c2eb816366228ca1694
doc_id: 791313
cord_uid: xb02s3kz

In Japan, the first case of COVID‐19 in dialysis patients was reported on March 1, 2020. A total of 31 cases were reported by April 10, and it increased to 95 by May 15. Thereafter, with the rapid increase in the number of COVID‐19 cases in the general population since late March, there was a not surprising increase in the number of COVID‐19 cases in dialysis patients. The mortality rate is 16.2% (16/99 cases) in dialysis patients, which is higher than 5.3% (874/16532 cases) in the general population. This higher mortality rate in dialysis patients with COVID‐19 might be related to their age; the majority of COVID‐19 cases are aged between 70 and 90 years in dialysis patients, compared with between 20 and 60 years in the general population. As COVID‐19 presents with severe symptoms and is associated with a high mortality rate in dialysis patients, dialysis patients who have contracted SARS‐CoV‐2 infection confirmed by polymerase chain reaction (PCR) testing are required to be hospitalized under Japanese government policy. In cases of COVID‐19 hospitalizations, it is essential to prevent nosocomial infection. Therefore, patients must be sufficiently instructed in infection prevention and robust measures to prevent contraction and spread of the infection must be taken at dialysis facilities. This article is protected by copyright. All rights reserved.

In Japan, the first patient with COVID-19, identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was detected on January 16, 2020, in patients with pneumonia who had visited Wuhan City. The number of confirmed cases of COVID-19 in Japan has gradually increased since then, and started rapidly increasing in late March. Therefore, to stem the spread of SARS-CoV-2 infection, the Japanese government decided to place all of Japan under a state of emergency on April 16.

To address measures for dialysis facilities, the Japanese Association of Dialysis Physicians has released guidance and its updates for infection control in dialysis patients with COVID-19 since the outbreak, on February 6, In Japan, the first case of COVID-19 in dialysis patients was reported on March 1, 2020. A total of 31 cases were reported by April 10, and then 99 by May 29 (Table 1) . With the rapid increase in the number of COVID-19 cases in the general population since late March, increase in the number of COVID-19 cases in dialysis patients was expected. We started data collection regarding the incident COVID-19 patients on dialysis since April 9 as well as known patients with the disease until then. The COVID-19

Control Joint Committee asked all dialysis facilities in Japan to report any patients who were confirmed to have COVID-19 to the committee by using a This article is protected by copyright. All rights reserved. Accepted Article dedicated Excel file. The collected data included patient background, medical history, the clinical course relating to COVID-19, symptoms, findings in chest X-ray or CT, and treatments against the disease. The data collection was approved by the ethical committee of the Japanese Society for Dialysis Therapy (approval #1-8). Confirmed cases of COVID-19 were more likely to be male (69 vs 29 cases, and 1 missing information), which may be the reflection of the gender ratio of the entire dialysis population in part. A total of 39 of 62 cases (62.9%, excluding the number of cases with missing information) had confirmed contact with a person with SARS-CoV-2 positive, in other words remaining 23 patients were considered infected without any known sources.

The mortality rate was 16.2% (16/99 cases) in dialysis patients, which was higher than 5.3% (874/16,532 cases) in the general population.

However, the high mortality rate in dialysis patients with COVID-19 might be related to their age; the majority of COVID-19 cases are aged between 70 and 90 yo in dialysis patients, compared with between 20 and 60 yo in the general population. In general, mortality rapidly increases after age 70 yo (Figures 1 and 2) . The mortality rate was 1.6 times higher in dialysis patients compared to the general population (30.4% [7/23 cases] vs 18.9%

[327/1,733 cases]) in those aged ≥80 yo; however, the gap is smaller.

The common symptom at the onset of illness was fever (body temperature of 37.5°C or higher), which was reported in 95.1% (79/83 cases, hospitalized, even in the absence of symptoms consistent with COVID-19, while the general population can be quarantined in designated accommodations outside of hospitals if they have no or little symptom. This is because dialysis patients are more likely to express more severe symptoms and this cohort's mortality rate is higher than that of the general population.

Under these circumstances, the local government and medical professionals involved in dialysis treatment (e.g., dialysis coordinators) must work together to secure hospital beds and determine hospitalization destinations based on severity.

the Japanese Association of Dialysis Physicians instructs the facilities to follow the following measures against COVID-19. 1) Instruct patients to measure body temperature and keep track of his/her health condition daily.

2) Instruct the patients to call dialysis facility to report fever or colds before their visit.

3) The doctor who receives the call from the patient makes a comprehensive judgment and contacts the COVID-19 consultation center if COVID-19 is suspected. This article is protected by copyright. All rights reserved.

Accepted Article

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the

Online ahead of print

Semple MG; ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

COVID-19 in Dialysis Patients: Adding a Few More Pieces to the Puzzle

A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection

The Mystery of the Pandemic's 'Happy Hypoxia

Coronavirus Drugs Trials Must Get Bigger and More Collaborative